期刊
AMERICAN JOURNAL OF TRANSPLANTATION
卷 14, 期 3, 页码 507-514出版社
WILEY
DOI: 10.1111/ajt.12567
关键词
ATP; P2X7R; purinergic system; rejection
资金
- JDRF-Career Development Award
- ASN Career Development Award
- ADA mentor-based fellowship
- Boston Children's Hospital
- Ministry of Health of Italy [RF-FSR-2008-1213704, RF-2010-2314794, RF-2010-2303119]
- Associazione Medici Diabetologi (AMD) - Societa' Italiana di Diabetologia (SID) Pasquale di Coste Scolarship
The purine nucleotide adenosine triphosphate (ATP) is a universal source of energy for any intracellular reaction. Under specific physiological or pathological conditions, ATP can be released into extracellular spaces, where it binds and activates the purinergic receptors system (i.e. P2X, P2Y and P1 receptors). Extracellular ATP (eATP) binds to P2X or P2Y receptors in immune cells, where it mediates proliferation, chemotaxis, cytokine release, antigen presentation and cytotoxicity. eATP is then hydrolyzed by ectonucleotidases into adenosine diphosphate (ADP), which activates P2Y receptors. Ectonucleotidases also hydrolyze ADP to adenosine monophosphate and adenosine, which binds P1 receptors. In contrast to P2X and P2Y receptors, P1 receptors exert mainly an inhibitory effect on the immune response. In transplantation, a prominent role has been demonstrated for the eATP/P2X7R axis; the targeting of this pathway in fact is associated with long-term graft function and reduced graft versus host disease severity in murine models. Novel P2X receptor inhibitors are available for clinical use and are under assessment as immunomodulatory agents. In this review, we will focus on the relevance of the purinergic system and on the potential benefits of targeting this system in allograft rejection and tolerance. This minireview summarizes the emerging role of the purinergic system in allograft rejection and focuses on the unique opportunities presented by newly developed drugs that target the purinergic system to promote long-term allograft survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据